Login

Exclusive Interview with Doxa CEO Jan Edöcs at Geneva - Jan Edöcs, CEO, Doxa 00:00:00

Share On Facebook Share On Twitter

Exclusive Interview with Doxa CEO Jan Edöcs at Geneva

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
An overview of Kape (formerly Crossrider) provided by CEO Ido Erlichman, offering strategic insights before the game-changing acquisition of LTMI Holdings| Ido Erlichman CEO of Kape technology ltd
00:10:00
Essential traits of curiosity and coachability|Shaun Arora, Managing Director at MiLA Capital
00:10:00
Geovariances | Jean-Jacques Péraudin's Description of Kartotrak | Jean Paul ROUX, MD, Geovariances (TS)
00:10:00
Leaders Discuss Solutions for the New Decade | Keiichi Yoshii, CEO , Daiwa house industry co.
00:10:00
WashingtonExec's Amanda Ziadeh interviews Mark Fialkowski, executive vice president at Parsons Corp., about emerging industry trends.
00:10:00
Monument Mining: Advancing Expansion and Exploration Efforts | Cathy Zhai - Director, President, CEO & Interim CFO of Monument Mining Limited
00:10:00
Innovative Financial Advisory Models with Spencer Sherman | Barbara Wolf - Financial Advisor of Abacus Wealth Partners
00:10:00
The business of turning powerful ideas into high-performing strategies and solutions.|Michael Tiedemann, CEO,Tiedemann Investment Group
00:10:00
TTG Weekly Update: July 12, 2024 - Inflation Trends and Portfolio Adjustments | Jim Kotagides, President , TTG Financial Inc.
00:10:00
Plateau Energy Metals: Advancing Lithium and Uranium Projects at the One-to-One Mining Investment Conference in London
00:10:00
CopperBank Advances Strategic Copper Projects in Safe Jurisdictions
00:10:00
The Secret to Citadel's Success | Mark McConnell, CEO, Citadel Group Ltd CGL:ASX

© 2026 Nehu